Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for 000650.SZ and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for 000650.SZ and 80,000+ other tickers.
See exactly how 000650.SZ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 000650.SZ and 80,000+ other tickers.
Renhe Pharmacy Co., Ltd. is a pharmaceutical enterprise engaged in the manufacturing and distribution of a wide array of products. Its diverse portfolio includes both traditional Chinese and modern Western medicines, their essential raw materials, and various health and wellness items. These offerings are presented in numerous forms, such as oral solid preparations (e.g., tablets, capsules), liquid medications, large and small volume injectable solutions, topical treatments like lotions, liniments, and ointments, as well as suppositories and other health-related product formats. The company, which was established in 1996, maintains its corporate headquarters in Nanchang, China.
No recent news available.